This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
このページの翻訳は実験的なもので、現在 開発中です。お待ちしております！
Clarus Therapeutics Holdings 将来の成長
Future 基準チェック /26
主要情報
43.9%
収益成長率
49.8%
EPS成長率
| Pharmaceuticals 収益成長 | 23.5% |
| 収益成長率 | 29.6% |
| 将来の株主資本利 益率 | n/a |
| アナリストカバレッジ | Low |
| 最終更新日 | n/a |
業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2025 | 62 | -8 | N/A | N/A | 1 |
| 12/31/2024 | 46 | -24 | N/A | N/A | 1 |
| 12/31/2023 | 32 | -35 | N/A | N/A | 1 |
| 12/31/2022 | 18 | -44 | N/A | N/A | 1 |
| 6/30/2022 | 17 | -24 | -57 | -57 | N/A |
| 3/31/2022 | 16 | -36 | -54 | -54 | N/A |
| 12/31/2021 | 14 | -40 | -44 | -44 | N/A |
| 9/30/2021 | 12 | -58 | -40 | -40 | N/A |
| 6/30/2021 | 10 | -50 | -40 | -40 | N/A |
| 3/31/2021 | 8 | -21 | -35 | -35 | N/A |
| 12/31/2020 | 6 | -10 | -42 | -42 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: CRXT.Q is forecast to remain unprofitable over the next 3 years.
収益対市場: CRXT.Q is forecast to remain unprofitable over the next 3 years.
高成長収益: CRXT.Q is forecast to remain unprofitable over the next 3 years.
収益対市場: CRXT.Q's revenue (29.6% per year) is forecast to grow faster than the US market (7.1% per year).
高い収益成長: CRXT.Q's revenue (29.6% per year) is forecast to grow faster than 20% per year.
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: Insufficient data to determine if CRXT.Q's Return on Equity is forecast to be high in 3 years time